Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.

Míreanna comhchosúla

• Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
  de réir: Anthony, D, et al.
  Foilsithe / Cruthaithe: (2014)
• Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis
  de réir: Anthony, D, et al.
  Foilsithe / Cruthaithe: (2012)
• Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
  de réir: Seneca, N, et al.
  Foilsithe / Cruthaithe: (2012)
• Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
  de réir: Leppert, D, et al.
  Foilsithe / Cruthaithe: (2012)
• Glial activation in the early stages of brain metastasis: TSPO as a diagnostic biomarker.
  de réir: O'Brien, E, et al.
  Foilsithe / Cruthaithe: (2014)